Background: Most of the times the prognosis of the patients with cancer who develop brain metastases remains incurable and hopeless with a median survival that goes between 2.7 and 15.07 month according to Grade Prognostic Assessment (GPA) Score for brain metastasis. Case summary: The following is a case report of a 33-year-old patient that presented with breast cancer and after one year of follow-up she developed one single brain metastases treated aggressively with surgery, whole brain radiotherapy (WBRT) 30 Gy in 10 Fractions and Stereotactic Radiosurgery (SRS) 22 Gy who achieved complete response and after more than 6 years since treatment the patient continues free of disease. Conclusion: An aggressive treatment for brain metastases in...
Breast cancer is the leading cause of brain metastases in women. Large randomized clinical trials th...
Despite improvements in brain surgery and radiotherapy, patients with brain metastases (BM) from bre...
Brain metastases (BM) occur in 20–40% of patients with cancer and 60–75% of patients with BM become ...
Background: Most of the times the prognosis of the patients with cancer who develop brain metastases...
Background Brain metastases occur in 10%–40% of patients with cancer and are more common than primar...
The incidence of brain metastases (BMs) is apparently rising in patients with advanced breast cancer...
Brain metastasis are the most common intracranial malignancy in the adult population. Their incidenc...
Abstract Brain metastases are significant causes of morbidity or mortality for patients with metasta...
Brain metastases are one of the most common palliative oncologic problems. Approximately 20% to 40% ...
Background and Aim: Breast cancer is the second most common cause of brain metastases after lung can...
Item does not contain fulltextPatients with cancer have a 15 to 30% risk of developing symptomatic b...
Thirty-four breast cancer patients with single brain metastases were reviewed: 9 underwent surgical ...
With an incidence of 15/10(5) in the general population, brain metastases constitute a serious, debi...
AIMS AND BACKGROUND: Late brain metastases from breast cancer are a rare event. Only a few cases...
The incidence of brain metastases (BMs) is apparently rising in patients with advanced breast cancer...
Breast cancer is the leading cause of brain metastases in women. Large randomized clinical trials th...
Despite improvements in brain surgery and radiotherapy, patients with brain metastases (BM) from bre...
Brain metastases (BM) occur in 20–40% of patients with cancer and 60–75% of patients with BM become ...
Background: Most of the times the prognosis of the patients with cancer who develop brain metastases...
Background Brain metastases occur in 10%–40% of patients with cancer and are more common than primar...
The incidence of brain metastases (BMs) is apparently rising in patients with advanced breast cancer...
Brain metastasis are the most common intracranial malignancy in the adult population. Their incidenc...
Abstract Brain metastases are significant causes of morbidity or mortality for patients with metasta...
Brain metastases are one of the most common palliative oncologic problems. Approximately 20% to 40% ...
Background and Aim: Breast cancer is the second most common cause of brain metastases after lung can...
Item does not contain fulltextPatients with cancer have a 15 to 30% risk of developing symptomatic b...
Thirty-four breast cancer patients with single brain metastases were reviewed: 9 underwent surgical ...
With an incidence of 15/10(5) in the general population, brain metastases constitute a serious, debi...
AIMS AND BACKGROUND: Late brain metastases from breast cancer are a rare event. Only a few cases...
The incidence of brain metastases (BMs) is apparently rising in patients with advanced breast cancer...
Breast cancer is the leading cause of brain metastases in women. Large randomized clinical trials th...
Despite improvements in brain surgery and radiotherapy, patients with brain metastases (BM) from bre...
Brain metastases (BM) occur in 20–40% of patients with cancer and 60–75% of patients with BM become ...